Check Point Software Technologies arrives at its July 30 earnings report with short sellers retreating sharply from the positions they built earlier this month — a meaningful shift from the setup described in the pre-July 24 preview.
The short interest story has reversed with some force. Estimated shares short dropped nearly 14% in a single session on July 24, pulling the total from a mid-month peak near 6.5 million shares down to roughly 5.5 million. That unwinding extends over the week as well, with a net decline of about 12% over five sessions. The borrow market confirms there is no squeeze pressure here: availability runs at 681%, meaning lenders hold nearly seven shares for every one already borrowed, and cost to borrow sits at just 0.55% — barely changed over the week. Options positioning has picked up marginally, with the put/call ratio rising to 0.49 on Monday from a recent run of readings near 0.40, but it remains less than a standard deviation above its 20-day average. None of these signals point to an anxious market.
The more charged story is in analyst positioning, which has turned notably active in the last week. JP Morgan downgraded to Neutral, pulling its conviction despite maintaining a $135 target — effectively removing the firm from the bull camp. BofA, also Neutral, lifted its target by $20 to $140. Those two moves together set the tone: the Street is raising its floor but not its ceiling. Raymond James downgraded to Market Perform in mid-July, while Scotiabank and Guggenheim upgraded in early July with targets of $185 and $188 respectively. The consensus sits at Hold with a mean target of $148.68, implying roughly 12% upside from the current price of $132.75 — enough to tempt, but not enough to prompt conviction. Bulls point to Infinity adoption and CTEM ramp as structural drivers, with the go-to-market reorganisation framed as a temporary drag. Bears cite slowing subscription growth, elongating sales cycles, and a forward EPS growth estimate that has deteriorated sharply over recent months.
The prior earnings event on April 30 produced a bruising one-day decline of 18%, with losses holding through the week. That reaction concentrated minds, and the short build through early-to-mid July likely reflected traders positioning for a repeat. The subsequent unwind into July 24's release — when the stock rose 5.3% on the day — suggests some of that bearish positioning was covered, though the stock is still down around 2% on the week heading into Thursday.
Thursday's print will test whether the reorganisation is genuinely behind the company or whether the structural headwinds are stickier than management's guidance implies — and whether the nascent analyst upgrades hold once the numbers are in front of them.
See the live data behind this article on ORTEX.
Open CHKP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
